findmyKOL
Clinical trialNCT04754542CompletedObservational

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

SponsorUniversity of Colorado, DenverEnrollment76Multiple Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado Denver

    Aurora, Colorado, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Mount Sinai

    New York, New York, United States

  • New York University

    New York, New York, United States

  • University of Rochester

    Rochester, New York, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • Swedish

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 May 2021
Primary completion
30 Nov 2022
Completion
30 Nov 2022
Last update posted
25 Sept 2024
Registered enrollment
76
Registry id
NCT04754542

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.